The American College of Cardiology (ACC) has issued guidance to help clinicians and patients use health data collected while wearing Apple Watch to effectively track and manage cardiovascular health. ...

Understand and strategically utilize the new program signaling feature for the 2026 Cardiovascular Fellowship MyERAS® application season. Join ACC's Program Directors and Graduate Medical Educators ...

Consumption of ultra-processed foods, such as sugar-sweetened beverages, potato chips and packaged cookies, may be associated with adverse health outcomes, according to research being presented at the ...

“Courtside with the Chair” is a series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this ...

A new study puts the spotlight on the rising burden of ischemic heart disease across Southeast Asia, East Asia and Oceania, and calls for localized, equity-focused interventions in these regions. The ...

A multi-center cohort study of patients in China with arrhythmogenic cardiomyopathy (ACM) is contributing important insights into understanding the disease and the unique genetic and clinical ...

Withdrawal of other heart failure treatment while maintaining carvedilol as a single therapy did not worsen left ventricular (LV) function compared to usual treatment at 52 weeks in patients with ...

Cardiovascular magnetic resonance (CMR) imaging was able to detect longer myocardial T 2, higher extracellular volume (ECV) fraction and worse myocardial dynamics, including impaired strain, before ...

Ischemia as detected by dobutamine stress echocardiography (DSE) predicted the placebo-controlled efficacy of PCI in patients with single- and multivessel stable coronary artery disease (CAD) taking ...

The use of IVUS to assess the coronary ostia at high risk for coronary artery obstruction (CAO) after TAVR is feasible, safe and potentially lifesaving, according to results from the ICARO study ...

With an increasing number of facilities and organizations adding an ambulatory surgery center (ASC) to their cardiovascular care delivery portfolio, and private payers beginning to engage with the ...

Colchicine substantially reduces major adverse cardiovascular events (MACE) including cardiovascular death, myocardial infarction (MI) and ischemic stroke compared with placebo in patients with ...